Aton Biotech is a fast-growing Contract Development and Manufacturing Organisation (CDMO) that is dedicated to facilitating the development of new biological drugs for clients through an integrated biopharmaceutical platform. The company offers a comprehensive range of services encompassing cell line development, clinical trial support, and end-to-end commercial manufacturing services. This includes the development of mammalian-expressed monoclonal antibodies, fusion proteins, bispecific antibodies, and antibody-drug conjugates (ADCs). Aton Biotech operates two state-of-the-art R&D and manufacturing facilities located in Shanghai, both of which are equipped with the latest technologies and adhere to the current Good Manufacturing Practice (cGMP) regulations set forth by the National Medical Products Administration of China (NMPA), the European Medicines Agency (EMA), and the U.S. Food and Drug Administration (FDA).

Services include:
- Bioanalytical Services
- Biological Testing
- Biologics
- Process Development
- Biosimilars
- Cell Culture Media Development
- Chemical Analysis
- Clinical Supply Management
- Chemistry (CMC)
- Manufacturing
- Sourcing
- Contract Development and Manufacturing (CDMO)
- Contract Manufacturing (CMO)
- Contract Research (CRO)
- Drug Delivery Devices
- Drug Development
- Fermentation
- Filling
- Syringe
- Vials
- Mammalian Cell Culture
- Antibody-Drug Conjugates
- Aseptic Fill-Finish
- Clinical Trial Materials
- Liquids
- Lyophilization
- Proteins
- Vaccines
- Process R&D
- Process Validation Studies
- Project Management
- Purification
- Quality QA/QC
- R&D Services
- Raw Materials Analysis
- Scale-Up
- Sterile Filling
- Technology Transfer
- Validation
- Cleaning Equipment
- Filtration

Aton Biotech remains committed to delivering high-quality solutions in the biopharmaceutical sector, enabling clients to bring their innovative therapies to market efficiently. For more information, please visit atonbio.com.